Huntingtin Antikörper (N-Term)
Kurzübersicht für Huntingtin Antikörper (N-Term) (ABIN4889208)
Target
Alle Huntingtin (HTT) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Reacts with the human Huntingtin protein
-
Kreuzreaktivität
- Maus, Ratte (Rattus)
-
Kreuzreaktivität (Details)
- Cross react with mouse and rat protein due to sequence homology.
-
Aufreinigung
- Purified (protein A)
-
Immunogen
- synthetic peptide derived from N terminal part of human Huntingtin
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Must be reconstituted in distilled water.
-
Konzentration
- 1 mg/mL
-
Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Haltbarkeit
- 24 months
-
-
- Huntingtin (HTT)
-
Andere Bezeichnung
- Huntingtin
-
Hintergrund
- Defects in HTT are the cause of Huntington disease (HD). HD is an autosomal dominant neurodegenerative disorder characterized by involuntary movements (chorea), general motor impairment, psychiatric disorders and dementia.
-
UniProt
- P42858
-
Pathways
- PI3K-Akt Signalweg, Hormone Transport, Transition Metal Ion Homeostasis, Tube Formation, Protein targeting to Nucleus, Dicarboxylic Acid Transport
Target
-